Director R&D, Companion Diagnostics (Carpinteria, CA) Relocation Assistance Available

Agilent Technologies
Job Location
6392 Via Real
Carpinteria, CA 93013
Job Description

Are you ready to make a real difference in Personalized Medicine? We are looking for highly motivated individuals to join our growing and dynamic Companion Diagnostics (CDx) organization within Agilent.


Agilent inspires and supports discoveries that advance the quality of life. We provide life science, diagnostic and applied market laboratories worldwide with instruments, services, consumables, applications and expertise. Agilent enables customers to gain the answers and insights they seek ---- so they can do what they do best: improve the world around us. Information about Agilent is available at

The main responsibilities of the Director, , Companion Diagnostics, R&D are to provide leadership and management to scientific and technical staff in the R&D function, to ensure projects are resourced adequately and sound decisions are made to meet the overall goals and timelines of the projects. The Director will oversee an R&D line organization focused on the companion diagnostic development cycle. He/She will implement and communicate the strategic and technical direction for the function. The Director will work frequently with pharmaceutical partners on complex projects and abstract problems requiring ability to make decisions and set strategies for achieving project goals. The Director works closely with cross-functional directors and managers within the CDx function to identify issues that may impact project milestones, and recommends appropriate action to be taken. Participates with the Chief Scientific Officer (CSO) function and corporate business development to grow the CDx business with new pharma collaborations and partnerships.

The Director, CDx R&D will also participate in setting functional strategies and milestones in meeting objectives for the CDx business, as well as process improvements and drive quality initiatives. The Director may also participate in Technology and Business initiatives as directed by the CSO.


Education: Advanced university degree in biological sciences, preferably Ph.D.

Experience: Minimum 8 years' experience in diagnostics and/or pharmaceutical/biotech with history of success in product and assay development in a regulating industry. Previous people management experience is required, with an emphasis on managing managers; experienced in working with external partners.

Special skills: Strong business acumen; familiarity or experience in project management; strong technical skills, knowledge of Quality System Regulations; excellent oral and written skills.


Agilent Technologies, Inc. is an Equal Employment Opportunity and Affirmative Action employer. We value diversity at all levels. All individuals, regardless of personal characteristics, are encouraged to apply. All qualified applicants will receive consideration for employment without regard to sex, pregnancy, race, religion or religious creed, color, gender, gender identity, gender expression, national origin, ancestry, physical or mental disability, medical condition, genetic information, marital status, registered domestic partner status, age, sexual orientation, military or veteran status, protected veteran status, or any other basis protected by federal, state, local law, ordinance, or regulation and will not be discriminated against on these bases.

For more information about equal employment opportunity protections, please view the 'EEO is the Law' poster available here:

A new analysis finds that better grant-writing skills may help early-career researchers stay funded and stay in academia.

At Nature, a graduate student describes how to explore careers outside academia and what PhD programs can do help that search.

A new analysis of research funding finds that after receiving their first award, female researchers are just about as likely to receive additional awards as male researchers.

The Nature Jobs blog reports that the University of Chicago is no longer requiring graduate school applicants to submit standardized test scores.